Suppr超能文献

肿瘤内 α-SMA 增强了 CD34 的预后效力,与肝癌和胰腺癌中小血管完整性的维持有关。

Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer.

机构信息

Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.

出版信息

PLoS One. 2013 Aug 5;8(8):e71189. doi: 10.1371/journal.pone.0071189. Print 2013.

Abstract

Microvessel density (MVD) as an angiogenesis predictor is inefficient per se in cancer prognosis. We evaluated prognostic values of combining intratumoral alpha-smooth muscle actin (α-SMA)-positive stromal cell density and MVD after curative resection in hypervascular hepatocellular carcinoma (HCC) and hypovascular pancreatic cancer (PC). Tissue microarrays were constructed from tumors of 305 HCC and 57 PC patients who underwent curative resection and analyzed for α-SMA and CD34 expression by immunostaining. Prognostic values of these two proteins and other clinicopathological features were examined. Both low α-SMA density and high MVD-CD34 were associated in HCC with the presence of intrahepatic metastasis and microvascular invasion, and they were related to lymph node involvement and microvascular invasion in PC (p<0.05). Although CD34 alone, but not α-SMA, was an independent prognostic factor for overall survival and recurrence-free survival, the combination of low α-SMA and high CD34 was a predictor of worst prognosis for both types of tumors and had a better power to predict patient death and early recurrence (p<0.01). Furthermore, the results show that distribution of most of the α-SMA-positive cells and vascular endothelial cells overlap, showing major colocalization on vascular walls. Poor microvessel integrity, as indicated by high MVD, together with low perivascular α-SMA-positive cell coverage is associated with early recurrence, unfavorable metastasis, and short survival after tumor resection. This finding highlights the significance of vascular quality in tumor progression, which provides an optimized complement to vascular quantity in prognosis of postoperative patients.

摘要

微血管密度(MVD)作为一种血管生成预测因子,本身在癌症预后中的效率并不高。我们评估了在富血管型肝细胞癌(HCC)和乏血管型胰腺癌(PC)患者根治性切除术后,联合肿瘤内α-平滑肌肌动蛋白(α-SMA)阳性基质细胞密度和 MVD 对预后的预测价值。从接受根治性切除的 305 例 HCC 和 57 例 PC 患者的肿瘤中构建组织微阵列,并通过免疫染色分析α-SMA 和 CD34 的表达。检查了这两种蛋白和其他临床病理特征的预后价值。在 HCC 中,低 α-SMA 密度和高 MVD-CD34 与肝内转移和微血管侵犯的存在有关,在 PC 中,它们与淋巴结受累和微血管侵犯有关(p<0.05)。尽管 CD34 是 HCC 患者总生存期和无复发生存期的独立预后因素,但低 α-SMA 和高 CD34 的组合是两种肿瘤预后最差的预测因子,并且具有更好的预测患者死亡和早期复发的能力(p<0.01)。此外,结果表明,大多数 α-SMA 阳性细胞和血管内皮细胞的分布重叠,在血管壁上表现出主要的共定位。微血管完整性差,MVD 高,伴有血管周围 α-SMA 阳性细胞覆盖低,与肿瘤切除后早期复发、不良转移和生存时间短有关。这一发现强调了血管质量在肿瘤进展中的重要性,为术后患者的预后提供了血管数量的优化补充。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/424f/3734294/e7ae8db12f53/pone.0071189.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验